Advisory Committee on Breast Cancer in Young Women (ACBCYW), 10811-10812 [2014-04084]

Download as PDF 10811 Federal Register / Vol. 79, No. 38 / Wednesday, February 26, 2014 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Form name Number of respondents Number of responses per respondent Avgerage burden per response (in hr) ........................................................... ........................ ........................ ........................ Type of respondents Total ........................................... Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2014–04135 Filed 2–25–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention tkelley on DSK3SPTVN1PROD with NOTICES Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting for the aforementioned subcommittee: Time and Date: 11:00 p.m.–2:00 p.m., Eastern Time, March 19, 2014. Place: Audio Conference Call via FTS Conferencing. Status: Open to the public. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference at the USA toll-free, dialin number, 1–866–659–0537 and the passcode is 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines, which have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific VerDate Mar<15>2010 17:24 Feb 25, 2014 Jkt 232001 validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2015. Purpose: This Advisory Board is charged with a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Discussed: The agenda for the conference call includes: Final Vote Tally for Joslyn Manufacturing Plant SEC Petition Action; Subcommittee and Work Group Updates; SEC Petition Evaluations Update for the April 2014 Advisory Board Meeting; Plans for the April 2014 Advisory Board Meeting; and Advisory Board Correspondence. The agenda is subject to change as priorities dictate. Contact Person for More Information: Theodore M. Katz, M.P.A., Designated Federal Official, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E–20, Atlanta, Georgia 30333, Telephone (513) 533–6800, Toll Free 1–800–CDC–INFO, Email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Total burden (in hr) 1,616 Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2014–04085 Filed 2–25–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee on Breast Cancer in Young Women (ACBCYW) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Times and Dates: 9:00 a.m.–5:30 p.m. EST, March 27, 2014 8:00 a.m.–12:00 p.m. EST, March 28, 2014 Place: Centers for Disease Control and Prevention, 4770 Buford Highway, Chamblee Building 107 1A/1B/1C, Atlanta, Georgia 30341 Status: The meeting is open to the public, for in-person or distance participation, limited only by the space and phone lines available. For offsite participation, call (1) toll free: 888–989– 8135 Participant passcode 4798; or (2) by Net Conference at URL https:// www.mymeetings.com/nc/join/ Conference number: PW4485905 Audience passcode: 4798; or (3) join the meeting directly at: https:// www.mymeetings.com/nc/ join.php?i=PW4485905&p=4798&t=c. Participants outside of the U.S. may join by calling toll free 1–415–228–4965 Participant passcode: 4798. Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly E:\FR\FM\26FEN1.SGM 26FEN1 10812 Federal Register / Vol. 79, No. 38 / Wednesday, February 26, 2014 / Notices among those at heightened risk) and promotes the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials. Matters for Discussion: The agenda will include discussions on the current and emerging topics related to breast cancer in young women. These may include applied research, public health communication, approaches to increase awareness around topics such as breast cancer risk, breast health, symptoms, diagnosis, and treatment of breast cancer in young women. Agenda items are subject to change as priorities dictate. Online PreRegistration Required: To expedite the security clearance process required for entry into a Federal building, all ACBCYW attendees must register for the meeting online at least seven days in advance at https://www.cdc.gov/cancer/ breast/what_cdc_is_doing/ meetings.htm. Please complete all the required fields before submitting your registration and submit no later than March 19, 2014. Each meeting day, attendees must provide CDC staff and security with driver’s license, state issued ID, or passport. Contact Person for More Information: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 5770 Buford Highway, NE., Mailstop K52, Atlanta, Georgia 30341, Telephone (770) 488–4518, Fax (770) 488–4760. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry. Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. tkelley on DSK3SPTVN1PROD with NOTICES [FR Doc. 2014–04084 Filed 2–25–14; 8:45 am] BILLING CODE 4163–18–P VerDate Mar<15>2010 17:24 Feb 25, 2014 Jkt 232001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Prevention and the Agency for Toxic Substances and Disease Registry. Centers for Disease Control and Prevention Catherine Ramadei, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) Notice of Cancellation/Correction: CDC published a notice in the Federal Register on December 27, 2013, Volume 78, Number 249, Pages 78964–78965, to announce a February 6, 2014, Audio Conference Call of the ABRWH–SDRR. This meeting was canceled due to a lack of quorum for the meeting. Notice will be provided when the meeting is rescheduled, in accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463). CDC published a cancellation notice in the Federal Register on February 14, 2014, Volume 79, Number 31, Pages 8970– 8971, that incorrectly identified the ABRWH–SDRR committee as the ‘‘Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)’’. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E–20, Atlanta Georgia 30333, Telephone (513) 533–6800, Toll Free 1 (800) CDC–INFO, Email ocas@cdc.gov. This notice is published less than the required 15 days prior to the start of the announced meeting, in accordance with Section 102–3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the meeting notification time requirement. Section 102–3.150(b) states the following: ‘‘In exceptional circumstances, the agency or an independent Presidential advisory committee may give less than 15 calendar days’’ notice, provided that the reasons for doing so are included in the advisory committee meeting notice published in the Federal Register.’’ In this case, the agency is giving less than 15 days’ notice due to the inability to have quorum for the meeting. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 [FR Doc. 2014–04086 Filed 2–25–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request Title: ACF Program Instruction: Children’s Justice Act OMB No.: 0970–0425 Description: The Program Instruction, prepared in response to the enactment of the Childrens Justice Act (CJA), Title II of Public Law 111–320, Child Abuse Prevention and Treatment Act Reauthorization of 2010, provides direction to the States and Territories to accomplish the purposes of assisting States in developing, establishing and operating programs designed to improve: (1) The assessment and investigation of suspected child abuse and neglect cases, including cases of suspected child sexual abuse and exploitation, in a manner that limits additional trauma to the child and the child’s family; (2) the assessment and investigation of cases of suspected child abuse-related fatalities and suspected child neglect-related fatalities; (3) the investigation and prosecution of cases of child abuse and neglect, including child sexual abuse and exploitation; and (4) the assessment and investigation of cases involving children with disabilities or serious health-related problems who are suspected victims of child abuse or neglect. This Program Instruction contains information collection requirements that are found in Public Law 111–320 at Sections 107(b) and 107(d), and pursuant to receiving a grant award. The information being collected is required by statute to be submitted pursuant to receiving a grant award. The information submitted will be used by the agency to ensure compliance with the statute; to monitor, evaluate and measure grantee achievements in addressing the investigation and prosecution of child abuse and neglect; and to report to Congress. Respondents: State Governments E:\FR\FM\26FEN1.SGM 26FEN1

Agencies

[Federal Register Volume 79, Number 38 (Wednesday, February 26, 2014)]
[Notices]
[Pages 10811-10812]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-04084]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women (ACBCYW)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Times and Dates:
    9:00 a.m.-5:30 p.m. EST, March 27, 2014
    8:00 a.m.-12:00 p.m. EST, March 28, 2014
    Place: Centers for Disease Control and Prevention, 4770 Buford 
Highway, Chamblee Building 107 1A/1B/1C, Atlanta, Georgia 30341
    Status: The meeting is open to the public, for in-person or 
distance participation, limited only by the space and phone lines 
available. For offsite participation, call (1) toll free: 888-989-8135 
Participant passcode 4798; or (2) by Net Conference at URL https://www.mymeetings.com/nc/join/Conference number: PW4485905 Audience 
passcode: 4798; or (3) join the meeting directly at: https://www.mymeetings.com/nc/join.php?i=PW4485905&p=4798&t=c.
    Participants outside of the U.S. may join by calling toll free 1-
415-228-4965 Participant passcode: 4798.
    Purpose: The committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly

[[Page 10812]]

among those at heightened risk) and promotes the early detection and 
support of young women who develop the disease. The advice provided by 
the Committee will assist in ensuring scientific quality, timeliness, 
utility, and dissemination of credible appropriate messages and 
resource materials.
    Matters for Discussion: The agenda will include discussions on the 
current and emerging topics related to breast cancer in young women. 
These may include applied research, public health communication, 
approaches to increase awareness around topics such as breast cancer 
risk, breast health, symptoms, diagnosis, and treatment of breast 
cancer in young women.
    Agenda items are subject to change as priorities dictate. Online 
Pre-Registration Required: To expedite the security clearance process 
required for entry into a Federal building, all ACBCYW attendees must 
register for the meeting online at least seven days in advance at 
https://www.cdc.gov/cancer/breast/what_cdc_is_doing/meetings.htm.
    Please complete all the required fields before submitting your 
registration and submit no later than March 19, 2014. Each meeting day, 
attendees must provide CDC staff and security with driver's license, 
state issued ID, or passport.
    Contact Person for More Information: Temeika L. Fairley, Ph.D., 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, CDC, 5770 Buford Highway, NE., 
Mailstop K52, Atlanta, Georgia 30341, Telephone (770) 488-4518, Fax 
(770) 488-4760.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and Agency for 
Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2014-04084 Filed 2-25-14; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.